Cornerstone Therapeutics to Host First Quarter 2011 Conference Call
May 06, 2011 08:30 ET
|
Cornerstone Therapeutics
CARY, NC--(Marketwire - May 6, 2011) - Cornerstone Therapeutics Inc. (NASDAQ: CRTX) today announced that it will host a conference call at 8:30 a.m. ET on Thursday, May 12, 2011, to discuss its...
Cornerstone Therapeutics Announces Upcoming Investor Events
April 18, 2011 08:30 ET
|
Cornerstone Therapeutics Inc.
CARY, NC--(Marketwire - Apr 18, 2011) - Cornerstone Therapeutics Inc. (NASDAQ: CRTX) today announced updates regarding key upcoming investor relations events.On Tuesday, May 3, 2011 at 2:10 p.m. EDT,...
Cornerstone Therapeutics Reports Fiscal Year 2010 Financial Results
March 03, 2011 07:00 ET
|
Cornerstone Therapeutics Inc.
CARY, NC--(Marketwire - March 3, 2011) - Cornerstone Therapeutics Inc. (NASDAQ: CRTX) today
reported full year and fourth quarter 2010 results. Total net revenues
were $125.3 million for the full...
Cornerstone Therapeutics Appoints Chief Financial Officer
February 03, 2011 08:00 ET
|
Cornerstone Therapeutics Inc.
CARY, NC--(Marketwire - February 3, 2011) - Cornerstone Therapeutics Inc. (NASDAQ: CRTX), a specialty pharmaceutical company focused on acquiring, developing and commercializing proprietary products...
Cornerstone Therapeutics to Voluntarily Withdraw Balacet(R) 325 and Additional Propoxyphene Medications
November 22, 2010 08:30 ET
|
Cornerstone Therapeutics Inc.
CARY, NC--(Marketwire - November 22, 2010) - Cornerstone Therapeutics Inc. (NASDAQ: CRTX) announced today that it will voluntarily remove three products containing propoxyphene from the U.S. market....
Cornerstone Therapeutics Reports Third Quarter 2010 Financial Results
November 04, 2010 16:05 ET
|
Cornerstone Therapeutics Inc.
CARY, NC--(Marketwire - November 4, 2010) - Cornerstone Therapeutics Inc. (NASDAQ: CRTX)
today reported net income of $0.8 million, or $0.03 per diluted share, for
the third quarter of 2010,...